Skip to content

Venrock Healthcare Capital Partners III, L.P. Insider Trading -- Recent SEC Form 4 Transactions

Venrock Healthcare Capital Partners III, L.P. (CIK 1738048) reported 18 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-11-04). Recent activity: Buy LYCA (8,305 shares), Buy LYCA (4,430 shares), Buy LYCA (1,000 shares), Buy LYCA (8,804 shares), Buy LYCA (200 shares). Source: SEC Form 4.

DateCompanyRoleTypeSharesValue
2026-11-04Lycia Therapeutics, Inc. (LYCA)10% OwnerBuy8,305$223,820
2026-10-30Lycia Therapeutics, Inc. (LYCA)10% OwnerBuy4,430$115,047
2026-10-30Lycia Therapeutics, Inc. (LYCA)10% OwnerBuy1,000$26,330
2026-10-30Lycia Therapeutics, Inc. (LYCA)10% OwnerBuy8,804$231,281
2026-10-30Lycia Therapeutics, Inc. (LYCA)10% OwnerBuy200$5,372
2026-10-30Lycia Therapeutics, Inc. (LYCA)10% OwnerBuy10,570$266,681
2026-10-27Lycia Therapeutics, Inc. (LYCA)10% OwnerBuy24,560$630,701
2026-10-27Lycia Therapeutics, Inc. (LYCA)10% OwnerBuy28,379$740,976
2026-10-27Lycia Therapeutics, Inc. (LYCA)10% OwnerBuy4.8M$0
2026-10-27Lycia Therapeutics, Inc. (LYCA)10% OwnerBuy1.9M$35.0M
2026-10-27Lycia Therapeutics, Inc. (LYCA)10% OwnerBuy8,261$222,799
2026-10-27Lycia Therapeutics, Inc. (LYCA)10% OwnerBuy8,729$225,557
2026-10-27Lycia Therapeutics, Inc. (LYCA)10% OwnerBuy31,067$833,838
2026-03-27KalVista Pharmaceuticals, Inc. (KALV)10% OwnerSell3,183$60,859
2026-03-27KalVista Pharmaceuticals, Inc. (KALV)10% OwnerSell174,485$3.0M
2026-03-27KalVista Pharmaceuticals, Inc. (KALV)10% OwnerSell160$2,805
2026-03-27KalVista Pharmaceuticals, Inc. (KALV)10% OwnerSell21,386$379,815
2026-03-27KalVista Pharmaceuticals, Inc. (KALV)10% OwnerSell15,417$290,148

Source: SEC Form 4 filings · as of 2026-11-04